Profound Medical Corp. (PROF) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Profound Medical reported revenue of $16.1M, up 50.7% from $10.7M the year before. Net income was -$42.6M (a -264.4% net margin), or $1.41 per diluted share. Gross margin was 70.8% and operating margin was -256.3%. Operating activities generated -$38.2M of cash, leaving -$38.4M of free cash flow. At fiscal year end, Profound Medical held $77.5M in total assets against $11.0M in total liabilities, including $59.7M of cash and equivalents.
Open the full interactive Profound Medical financials → Quarterly statements, key ratios, valuation history and price charts.
Profound Medical Key Stats
| Share Price | $7.01 |
|---|---|
| Market Cap | $254.8M |
| P/E Ratio | 5.0 |
| Revenue YoY Growth | +50.7% |
| 52-Week Range | $5.06 – $8.65 |
| Shares Outstanding | 36.4 million (basic, 2026 Q2) |
Profound Medical Income Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Revenue | $10.7M | $16.1M |
| Gross Profit | $7.0M | $11.4M |
| Operating Income | -$33.1M | -$41.3M |
| Pre-Tax Income | -$27.8M | -$42.3M |
| Income Tax | -$2,000 | $252,000 |
| Net Income | -$27.8M | -$42.6M |
| Diluted EPS | $1.12 | $1.41 |
Profound Medical Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $5.3M | $6.0M | $5.3M | $2.5M |
| Net Income | -$8.0M | -$8.2M | -$7.1M | -$9.5M |
| Diluted EPS | $0.26 | -$0.27 | $0.19 | -$0.26 |
Profound Medical Balance Sheet
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash & Equivalents | $54.9M | $59.7M |
| Current Assets | $69.1M | $76.1M |
| Total Assets | $70.2M | $77.5M |
| Current Liabilities | $6.6M | $6.1M |
| Total Long-Term Debt | $4.7M | $4.5M |
| Total Liabilities | $9.8M | $11.0M |
| Shareholders' Equity | $60.4M | $66.4M |
Profound Medical Cash Flow Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash From Operations | -$23.5M | -$38.2M |
| Cash From Investing | — | -$242,000 |
| Cash From Financing | $54.7M | $41.1M |
| Free Cash Flow | — | -$38.4M |
Figures from Profound Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Profound Medical financials page for every line item.
Profound Medical Company Profile
| Ticker | PROF |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Mississauga, Ontario, Canada |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001628808 |
Frequently Asked Questions
What was Profound Medical's revenue in fiscal 2025?
Profound Medical (PROF) reported revenue of $16.1M for fiscal 2025.
What was Profound Medical's net income in fiscal 2025?
Profound Medical reported net income of -$42.6M for fiscal 2025.
What was Profound Medical's earnings per share (EPS) in fiscal 2025?
Profound Medical's diluted EPS was $1.41 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Profound Medical generate in fiscal 2025?
Profound Medical generated -$38.4M of free cash flow in fiscal 2025.
What was Profound Medical's revenue last quarter?
In its most recent reported quarter (2026 Q2), Profound Medical reported revenue of $2.5M.
How much debt does Profound Medical have?
Profound Medical reported $4.5M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Profound Medical are outstanding?
Profound Medical reported a weighted average of 36.4 million basic shares outstanding in 2026 Q2.
What is Profound Medical's market cap?
Based on its latest closing price, Profound Medical (PROF) has a market capitalization of about $254.8M.
When does Profound Medical's fiscal year end?
Profound Medical's fiscal year end, as registered with the SEC, is December 31.
Where is Profound Medical headquartered?
Profound Medical lists its business address in Mississauga, Ontario, Canada in its SEC filings.
Profound Medical Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →